Quartesian Founders Launch Acrosian, AI-Native Biometrics CRO
- Three former Quartesian co-founders (Jackson, Chowdhury, Mats) launched Acrosian on July 28, 2026, as a biometrics and data sciences CRO focused on AI-augmented data management, biostatistics, statistical programming, and medical writing.
- Acrosian's model embeds AI workflows within GxP-compliant frameworks with explicit human accountability and auditability, positioning itself to address commoditization pressure in traditional biometrics CRO services.
- The venture targets emerging biotechs and global pharma sponsors seeking AI-driven efficiency in regulatory submission packages without sacrificing compliance rigor.
Operational Impact
Acrosian's launch introduces a new biometrics CRO competitor focused on AI-augmented workflows for data management and biostatistics, potentially reshaping vendor selection for sponsors seeking validated, compliance-ready AI integration in regulatory submissions.
Source: PharmaSource RSS